Anzeige
Mehr »
Login
Montag, 27.01.2020 Börsentäglich über 12.000 News von 622 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 884113 ISIN: US1011371077 Ticker-Symbol: BSX 
Tradegate
24.01.20
12:31 Uhr
39,045 Euro
-0,370
-0,94 %
Branche
Gesundheitswesen
Aktienmarkt
S&P 500
1-Jahres-Chart
BOSTON SCIENTIFIC CORPORATION Chart 1 Jahr
5-Tage-Chart
BOSTON SCIENTIFIC CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
38,865
39,255
26.01.
39,050
39,300
24.01.

Aktuelle News zur BOSTON SCIENTIFIC Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoBoston Sci wins CE Mark for disposable duodenoscope Exalt Model D1
BOSTON SCIENTIFIC Aktie jetzt für 4€ handeln
17.01.Boston Scientific to appeal order to finish failed $275M merger2
17.01.Boston Scientific Gets a Boost From New Products, Buyouts1
16.01.Boston Scientific wins a round in patent spat with Micro-Tech2
16.01.Global Vascular Embolization Devices Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Boston Scientific Corp. | Technavio255The global vascular embolization devices market is expected to grow by USD 1 billion during 2020-2024, progressing at a CAGR of almost 6% during the forecast period. The growth of the market can be...
► Artikel lesen
15.01.Boston Scientific Stock Dips on Dull Preliminary Q4 Results2
14.01.Boston Scientific shares drop on Q4 sales news15
14.01.Boston Scientific down 6% on preliminary 2019 revenue15
14.01.Boston Scientific's stock falls after downbeat sales update18
14.01.Boston Scientific Prelim. Organic Sales Growth Below Its Outlook; Stock Plunges199WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX) reported fourth-quarter sales, based upon preliminary unaudited financial information, of approximately $2.90 billion, up approximately...
► Artikel lesen
14.01.BOSTON SCIENTIFIC CORP - 8-K, Current Report4
09.01.Global 3D Cardiac Mapping Systems Market 2019-2023 | Evolving Opportunities with Abbott and Boston Scientific Corporation | Technavio297The global 3D cardiac mapping systems market is poised to grow by USD 412.6 million during 2019-2023, progressing at a CAGR of around 10% during the forecast period. Request free sample pagesThis...
► Artikel lesen
06.01.Global Neuromodulation Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Boston Scientific Corp. | Technavio246Technavio has been monitoring the global neuromodulation market since 2019 and the market is poised to grow by USD 5.2 billion during 2020-2024, progressing at a CAGR of more than 11% during the forecast...
► Artikel lesen
23.12.19Athenex Mixed Results, Boston Scientific Approval, And Other News: The Good, Bad, And Ugly Of Biopharma5
19.12.19Boston Scientific Ordered to Finish Scuttled Data-Fraud Deal2
19.12.19Judge orders Boston Scientific to complete $275 million merger1
18.12.19BOSTON SCIENTIFIC CORP - 8-K, Current Report6
17.12.19Boston Scientific Hits New 52-Week High: What's Driving it?5
17.12.19Boston Scientific's First Single-Use Duodenoscope Gets FDA Nod-
13.12.19FDA clears Boston Scientific's disposable duodenoscope, the world's first3
Seite:  Weiter >>
114 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1